Bioscience Animal Health PCL

Bioscience Animal Health PCL Current Assets

The Current Assets of Bioscience Animal Health PCL (BIS.BK) as of Oct 18, 2026 is 610.98 M THB. In the previous year, Current Assets was 1.02 B THB — a change of -40.05% (lower).

Current Assets

610.98 MTHB

YoY

-40.05%

Last updated:

Current Assets of Bioscience Animal Health PCL is 2025 610.98 M THB. Current Assets of Bioscience Animal Health PCL was 2024 1.02 B THB. It decreases by -40.05% lower compared to the previous year.

The Bioscience Animal Health PCL Current Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Assets
Date
Current Assets
Jan 1, 2018
117.26 M THB
Jan 1, 2019
96.88 M THB
Jan 1, 2020
627.40 M THB
Jan 1, 2021
720.23 M THB
Jan 1, 2022
848.39 M THB
Jan 1, 2023
1.02 B THB
Jan 1, 2024
1.02 B THB
Jan 1, 2025
610.98 M THB
The Bioscience Animal Health PCL Current Assets history
YEARCurrent AssetsYoY
610.98 MTHB-40.05%
1.02 BTHB-0.43%
1.02 BTHB+20.65%
848.39 MTHB+17.79%
720.23 MTHB+14.80%
627.40 MTHB+547.62%
96.88 MTHB-17.38%
117.26 MTHB+43.01%
81.99 MTHB—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Bioscience Animal Health PCL Stock analysis

What does Bioscience Animal Health PCL do? Bioscience Animal Health PCL, listed on the Stock Exchange of Thailand with ticker BIS.BK and ISIN THA776010003, operates in the Health Care sector. The company is headquartered in Pak Kret, Thailand, and completed its initial public offering on May 5, 2022. Bioscience Animal Health PCL is engaged in the manufacturing, importing, and distribution of medical supplies, tools, equipment, and products for livestock and pets. The company emphasizes collaboration with specialist veterinarians to select products aimed at enhancing animal health. Its product portfolio includes antibiotics, additives, BiSMiX B-Series, BiSMiX SD Series, injections, mold inhibitors, water-soluble products, and vaccines. Specific antibiotic products mentioned are Omnicide FG II 1 Lit, Green Bioxide 20Liter, Salinopharm, Cevazuril, and Porcillin. Injection products include Zuprevo, Nuflor, Ceva, and Enzaprost. The company also provides services such as comprehensive farm advisory, disease prevention and surveillance programs, serological examination and diagnosis, biosafety and hygiene management, analysis of feed raw materials, preparation of feed formulations, feed production inspection and monitoring, and management and upskilling of farm personnel. The company's website is https://bis-group.com/. Bioscience Animal Health PCL is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Bioscience Animal Health PCL stock

Current Assets of Bioscience Animal Health PCL is 610.98 M THB in 2025.

Current Assets of Bioscience Animal Health PCL changed from 1.02 B THB to 610.98 M THB, representing a -40.05% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Current Assets Bioscience Animal Health PCL since 2006 – with annual values, charts, and detailed analysis.

Current assets are assets expected to be converted to cash within one year, including cash, receivables, and inventory.

Current Assets's THB is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Assets's Bioscience Animal Health PCL historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Bioscience Animal Health PCL

All Key Metrics — Bioscience Animal Health PCL